Region-Based and Lesion-Based Analysis
| Analysis | CT or MRI | DMSA-V | 18F-FDG PET | 18F-DOPA PET | 18F-DOPA PET with CT |
|---|---|---|---|---|---|
| Positive regions | |||||
| Head | 3 | 2 | 0 | 4 | 4 |
| Neck | 4 | 3 | 4 | 8 | 8 |
| Thorax | 2 | 0 | 2 | 6 | 6 |
| Liver | 4 | 1 | 3 | 8 | 8 |
| Abdomen | 0 | 1 | 1 | 3 | 3 |
| Bone | 4 | 2 | 2 | 4 | 4 |
| Total | 17 (52%, 33%–69%) | 9 (33%, 16%–54%) | 12 (48%, 28%–69%) | 33 (89%, 74%–97%) | 33 (89%, 74%–97%) |
| Positive lesions | |||||
| Head | 3 | 4 | 0 | 4 | 8 |
| Neck | 7 | 6 | 7 | 13 | 13 |
| Thorax | 15 | 0 | 9 | 18 | 20 |
| Liver | 28 | 4 | 10 | 47 | 50 |
| Abdomen | 0 | 1 | 2 | 5 | 5 |
| Bone | 27 | 5 | 3 | 8 | 27 |
| Total | 80 (64%, 55%–72%) | 20 (19%, 12%–26%) | 31 (30%, 23%–39%) | 95 (71%, 62%–78%) | 119 (89%, 82%–94%) |
Number of positive regions and lesions per modality are given. Sensitivities and confidence intervals are given only for the rows in which total results for region-based and lesion-based analysis are presented. Sensitivities were calculated using composite reference data limited to patients scanned with the indicated imaging modality.